Behavioral Resources and Awareness for Veterans With Episodic Migraine: Impact on Neurological Disability and Quality of Life- Pilot
Brave-Mind
2 other identifiers
interventional
24
1 country
2
Brief Summary
The current study will evaluate effectiveness of cognitive behavioral therapy for migraine compared to migraine education (ME) to improve migraine-related quality of life in the real-world setting of the Veterans Health Administration (VHA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2026
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2026
CompletedFirst Posted
Study publicly available on registry
August 28, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
Study Completion
Last participant's last visit for all outcomes
October 1, 2027
August 28, 2026
August 1, 2026
1 year
August 24, 2026
August 24, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Retention Rate
Percent of randomized participants who complete Week 12 primary endpoint measure.
From randomization to week 12
Feasibility of Intervention
Average % of CBTm/ME sessions attended
From randomization to week 12
Study Arms (2)
Cognitive behavioral therapy for migraine (CBTm)
EXPERIMENTALParticipants to receive 6 sessions of CBTm
Migraine education intervention (MEintervention)
EXPERIMENTALParticipants to receive 6 sessions of a remotely delivered interactive MEintervention
Interventions
A standardized multi-modal behavioral treatment protocol typically delivered by psychologists via six sessions to help people better manage their migraine through behavior changes, warning sign identification and acute treatment optimization, medication adherence, and restructuring unhelpful thoughts about migraine and stress.
A digital intervention delivered via six 15-minute remote education sessions with a study research assistant from the VA Connecticut coordination center.
Eligibility Criteria
You may qualify if:
- Physician diagnosis of migraine
- Fluent in English
- Capacity to consent
- Currently meets ICHD-3 migraine criteria
- Self-report 4-14 monthly headache days in past 28 days
- Score of at least moderate disability (≥ 10) on the MIDAS
You may not qualify if:
- Secondary headache only
- Currently meets criteria for a Trigeminal Autonomic Cephalalgia
- Self-report \< 4 or \>14 headache days in past 28 days
- Utilization of behavioral treatments for migraine or pain in the past 12 months
- Score of less than 10 on the MIDAS
- Reports active suicidal ideation (endorses Ideation items 3, 4 or 5, or any Suicidal Behavior items in the past 12 months
- Has a pending disability or service connection claim related to migraine or headache disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
VA Connecticut Healthcare System
West Haven, Connecticut, 06516, United States
VA South Texas Healthcare System
San Antonio, Texas, 78224, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jason Sico, MD
VA Connecticut Healthcare System
- PRINCIPAL INVESTIGATOR
Margaret Bauer, PhD
VA Connecticut Healthcare System
- PRINCIPAL INVESTIGATOR
Nicholas Rattray, PhD
Richard L. Roudebush VA Medical Center
- PRINCIPAL INVESTIGATOR
Daniel Rogers, PhD
VA Connecticut Healthcare System
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2026
First Posted
August 28, 2026
Study Start (Estimated)
October 1, 2026
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
October 1, 2027
Last Updated
August 28, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share
As required by studies funded by the NIH/VA/Department of Defense Pain Management Collaboratory, the database created through this project will be made available to future VA investigators for a period of 10 years through an NIH HEAL-compliant repository (Vivli) which is currently being used for a VA cooperative study. Data will be disposed of 10 years following the completion of the study, as required by the National Institutes of Health. Only members of the research team at the VA will have access to the crosswalk. Banked data